Cronin Group PLC Directorate Changes (3298D)
April 26 2017 - 1:01AM
UK Regulatory
TIDMCRON
RNS Number : 3298D
Cronin Group PLC
26 April 2017
26 April 2017
Cronin Group Plc
("Cronin" or the "Company")
Directorate changes
Cronin Group PLC (the "Company") is pleased to announce the
appointment of Mark Warne as Executive Chairman. Mark brings broad
experience in building high growth businesses and commercial
engagement, as well as in managing transactions including portfolio
company IPOs, financings and M&A. Mark has been working with
the Company management team since joining the Board of Directors in
a non-executive capacity in September 2015. James Ede-Golightly
will continue to serve on the Board as a non-executive
director.
In addition the Company is pleased to announce the appointment
of Laurence Ede as independent non-executive director. Laurence has
been serving in an advisory capacity with the Company since April
2016 and brings specific experience of the chemicals industry to
Cronin Group Plc. He was the Managing Director and co-owner of
Tocris Bioscience, a company producing chemical compounds for
pharmaceutical research, when it was sold to Techne Corporation for
GBP75 million in 2011. Laurence is currently a non-executive
director of Ubiquigent Ltd, a drug discovery services company using
research tools and chemistry to pursue ubiquitin system-focused
drug discovery programmes.
Mark Warne said: "I am excited to take up the role of Executive
Chairman at Cronin Group. The Company has grown substantially in
recent months and I am impressed by the drive and determination of
our employees as they progress development of DigitalGlassware(TM).
I look forward to guiding the management team in the shaping and
delivery of the commercial plan and taking every opportunity to
make this business successful with its customers and markets.
Furthermore, I want to thank James for his a significant
contribution to the Board since he joined over three years ago and
I look forward to continuing to work with him as the Group seeks to
achieve its objectives. I also want to welcome Laurence to the
Board. He is highly experienced and has great knowledge of the
chemistry and pharmaceutical industry. Working in an advisory
capacity, Laurence has already helped us in how we go about
addressing the market opportunity available to the Company."
The following details in relation to the appointment of Mr Ede,
aged 45 are disclosed in accordance with Schedule 2(g) of the AIM
Rules:
Current directorships Past directorships held
within the last five years
---------------------------- ----------------------------
Manor Road Lettings Limited Tocris Cookson Limited
Ubiquigent Limited Tocris Holdings Limited
Tocris Investment Limited
There are no other disclosures in accordance with Schedule 2(g)
of the AIM Rules.
Contacts:
Cronin Group Plc www.croningroupplc.com
Mark Warne, Executive T: 0141 465 6871
Chairman
WH Ireland Limited www.whirelandplc.com
Mike Coe / Ed Allsopp T: 0117 945 3470
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOABELLLDZFFBBE
(END) Dow Jones Newswires
April 26, 2017 02:01 ET (06:01 GMT)
Deepmatter (LSE:DMTR)
Historical Stock Chart
From Apr 2024 to May 2024
Deepmatter (LSE:DMTR)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about Deepmatter Group Plc (London Stock Exchange): 0 recent articles
More Cronin News Articles